These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7827869)

  • 1. Future paradigm for autologous bone marrow transplantation: tumor purging and ex vivo production of normal stem and progenitor cells.
    Rummel SA; Van Zant G
    J Hematother; 1994; 3(3):213-8. PubMed ID: 7827869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft purging in autologous bone marrow transplantation: a promise not quite fulfilled.
    Alvarnas JC; Forman SJ
    Oncology (Williston Park); 2004 Jun; 18(7):867-76; discussion 876-8, 881, 884. PubMed ID: 15255171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purging of autologous bone marrow for transplantation: the protection and selection of the hematopoietic progenitor cell.
    Shpall EJ; Stemmer SM; Johnston CF; Hami L; Bearman SI; Berenson R; Jones RB
    J Hematother; 1992; 1(1):45-54. PubMed ID: 1365017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.
    Balzarotti M; Grisanti S; Granzow K; Saladini A; Sala A; Nozza A; Molteni A; Passamonti F; Carlo-Stella C; Santoro A; Siena S
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):66-71. PubMed ID: 10348263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model.
    Gravatt LC; Chaffee S; Hebert ME; Halperin EC; Friedman HS; Kurtzberg J
    Leukemia; 1993 Aug; 7(8):1261-7. PubMed ID: 8350627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purging in autologous and allogeneic bone marrow transplantation.
    Gulati SC; Lemoli RM; Acaba L; Igarashi T; Wasserheit C; Fraig M
    Curr Opin Oncol; 1992 Apr; 4(2):264-71. PubMed ID: 1591301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging.
    Lundell BI; Vredenburgh JJ; Tyer C; DeSombre K; Smith AK
    Bone Marrow Transplant; 1998 Jul; 22(2):153-9. PubMed ID: 9707023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation.
    Verdonck LF; Heesbeen EC; van Heugten HG; Staal GE; Rijksen G
    Bone Marrow Transplant; 1992 Apr; 9(4):241-5. PubMed ID: 1600412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood stem cells differ from bone marrow stem cells in cell cycle status, repopulating potential, and sensitivity toward hyperthermic purging in mice mobilized with cyclophosphamide and granulocyte colony-stimulating factor.
    Wierenga PK; Setroikromo R; Kamps G; Kampinga HH; Vellenga E
    J Hematother Stem Cell Res; 2002 Jun; 11(3):523-32. PubMed ID: 12183837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
    Stilz R; Grünebach F; Bader P; Vogel W; Kanz L; Brugger W; Scheding S
    J Hematother Stem Cell Res; 2001 Dec; 10(6):777-85. PubMed ID: 11798504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow purging for autologous bone marrow transplantation.
    Gribben JG; Nadler LM
    Leuk Lymphoma; 1993; 11 Suppl 2():141-8. PubMed ID: 8124225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prompt haemopoietic reconstitution following hyperthermia purged autologous marrow and peripheral blood stem cell transplantation in acute myeloid leukaemia.
    Herrmann RP; O'Reilly J; Meyer BF; Lazzaro G
    Bone Marrow Transplant; 1992 Sep; 10(3):293-5. PubMed ID: 1358379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus.
    Rahman MM; Madlambayan GJ; Cogle CR; McFadden G
    Cytokine Growth Factor Rev; 2010; 21(2-3):169-75. PubMed ID: 20211576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progenitor cells purging: negative selection.
    De Rosa L; Montuoro A; Pandolfi A; Paladini U; Lanti T; Morara R; De Laurenzi A
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():102-7. PubMed ID: 8013965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone marrow transplantation with alkyl-lysophospholipid-purged marrow.
    Vogler WR; Berdel WE
    J Hematother; 1993; 2(1):93-102. PubMed ID: 7921970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of amifostine in bone marrow purging.
    Cagnoni PJ; Jones RB; Bearman SI; Ross M; Hami L; Franklin WA; Capizzi R; Schein PS; Shpall EJ
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):44-8. PubMed ID: 8783666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of CD34 selection and complement-mediated immunopurging (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells.
    Nimgaonkar M; Kemp A; Lancia J; Ball ED
    J Hematother; 1996 Feb; 5(1):39-48. PubMed ID: 8646480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.